Literature DB >> 7436463

Familial myelofibrosis.

C A Sieff, P Malleson.   

Abstract

Two siblings developed a fulminant fatal myeloproliferative disease at 7 and 8 weeks of age. The illness presented with pallor, haemorrhagic symptoms, and hepatosplenomegaly, and the blood picture was that of pancytopenia and leucoerythroblastosis. Bone marrow histology showed reduced haemopoiesis with generalised fibrosis. Histiocytes were present, but haemophagocytosis was not prominent. There was evidence of extramedullary haemopoiesis in the spleen, with a chronic inflammatory infiltrate of other organs. The condition closely resembles acute idiopathic myelofibrosis of infancy, but the early onset with severe pancytopenia and the histological appearances may arouse suspicion of the possible familial nature of the condition. Although clinically resembling familial haemophagocytic reticulosis, the uncharacteristic bone marrow, liver, and spleen histology serve to exclude this diagnosis.

Entities:  

Mesh:

Year:  1980        PMID: 7436463      PMCID: PMC1626967          DOI: 10.1136/adc.55.11.888

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Myelofibrosis simulating acute leukaemia in a female infant with Down's syndrome.

Authors:  F Hillman; R M Forrester
Journal:  Ir J Med Sci       Date:  1968-04       Impact factor: 1.568

2.  [Familial myeloid splenomegaly].

Authors:  J Bernard; M Seligmann; C Loirat; J Chassigneux; A Basch; A Gueudet
Journal:  Nouv Rev Fr Hematol       Date:  1967 Jul-Aug

3.  Down's syndrome associated with a myeloproliferative disorder.

Authors:  H Okada; P I Liu; T Hoshino; T Yamamoto; H Yamaoka; M Murakami
Journal:  Am J Dis Child       Date:  1972-07

4.  Myelofibrosis with C monosomy of marrow elements in a child.

Authors:  J D Holden; F U Garcia; M Samuels; C Dupin; B Stallworth; E Anderson
Journal:  Am J Clin Pathol       Date:  1971-05       Impact factor: 2.493

5.  Myelofibrosis and myeloid leukaemia.

Authors:  P A Krasilnikoff
Journal:  Acta Paediatr Scand       Date:  1967-07

6.  Myelofibrosis in pediatric age group.

Authors:  M S Tobin; C Tan; S A Argano
Journal:  N Y State J Med       Date:  1969-04-15

7.  Familial myeloproliferative disease. A new syndrome closely simulating myelogenous leukemia in childhood.

Authors:  D L Randall; C W Reiquam; J H Githens; A Robinson
Journal:  Am J Dis Child       Date:  1965-11

8.  Myelofibrosis-myeloid metaplasia in childhood.

Authors:  L A Boxer; B M Camitta; W Berenberg; J P Fanning
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

Review 9.  The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.

Authors:  H P Ward; M H Block
Journal:  Medicine (Baltimore)       Date:  1971-09       Impact factor: 1.889

10.  Acute myelofibrosis in children with Down's syndrome.

Authors:  D I Evans
Journal:  Arch Dis Child       Date:  1975-06       Impact factor: 3.791

View more
  3 in total

1.  Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.

Authors:  K Hussein; A Stucki-Koch; G Göhring; H Kreipe; M Suttorp
Journal:  Leukemia       Date:  2017-02-27       Impact factor: 11.528

2.  Myeloproliferative Neoplasms in Children.

Authors:  Inga Hofmann
Journal:  J Hematop       Date:  2015-08-02       Impact factor: 0.196

3.  Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.

Authors:  Inga Hofmann; Mitchell J Geer; Timo Vögtle; Andrew Crispin; Dean R Campagna; Alastair Barr; Monica L Calicchio; Silke Heising; Johanna P van Geffen; Marijke J E Kuijpers; Johan W M Heemskerk; Johannes A Eble; Klaus Schmitz-Abe; Esther A Obeng; Michael Douglas; Kathleen Freson; Corinne Pondarré; Rémi Favier; Gavin E Jarvis; Kyriacos Markianos; Ernest Turro; Willem H Ouwehand; Alexandra Mazharian; Mark D Fleming; Yotis A Senis
Journal:  Blood       Date:  2018-06-13       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.